Subscribe to these results:

Past Workshops

  1. Highlights from the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting
    Part II of Equity. Every Patient. Every Day. Everywhere.
  2. Transplantation as a Treatment Option for Blood Cancers
  3. Update on Marginal Zone Lymphoma (MZL)
  4. What’s New in Diagnostic Technologies for People Living with Blood Cancers
    Part II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
  5. Progress in the Treatment of Non-Hodgkin Lymphoma (NHL)
  6. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
  7. Update on Diffuse Large B-Cell Lymphoma (DLBCL)
  8. Update on CAR T-Cell Therapies
  9. Coping with the Stresses of Caregiving When Your Loved One Has Mantle Cell Lymphoma (MCL)
    Part II of Living with Mantle Cell Lymphoma
  10. Progress in the Treatment of Waldenstrom’s Macroglobulinemia (WM)
  11. Treatment Update on Mantle Cell Lymphoma (MCL)
    Part I of Living with Mantle Cell Lymphoma
  12. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
  13. Progress in the Treatment of Follicular Lymphoma
  14. Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
  15. Update on Diffuse Large B-Cell Lymphoma (DLBCL)
  16. New Perspectives in the Treatment of Peripheral T-Cell Lymphoma (PTCL)
  17. What’s New in the Treatment of Hodgkin Lymphoma
  18. Highlights from the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting: Unite and Conquer: Accelerating Progress Together
    Part II of Your Guide to the Latest Cancer Research and Treatment
  19. Treatment Update on Mantle Cell Lymphoma (MCL)
  20. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
  21. Progress in the Treatment of Non-Hodgkin Lymphoma (NHL)
  22. Taking Your Blood Cancer Treatment on Schedule
  23. The Latest News in the Treatment of Waldenstrom’s Macroglobulinemia (WM)
  24. Caregiving for Your Loved One with Mantle Cell Lymphoma
  25. Update on Diffuse Large B-Cell Lymphoma
  26. For Caregivers: Coping with a Loved One’s Waldenstrom’s Macroglobulinemia (WM)
  27. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
  28. Progress in the Treatment of Hodgkin Lymphoma
  29. Update on Cutaneous T-Cell Lymphoma
  30. Progress in the Treatment of Non-Hodgkin Lymphoma (NHL)
  31. Update on Diffuse Large B-Cell Lymphoma
  32. Treatment Update on Mantle Cell Lymphoma
  33. Progress in the Treatment of Waldenstrom’s Macroglobulinemia (WM)
  34. Progress in the Treatment of Follicular Lymphoma
  35. Update on Marginal Zone Lymphoma
  36. Update on CAR-T Cell Therapy for People Living with Lymphoma
  37. Update on Mantle Cell Lymphoma
  38. The Emerging Role of Immunotherapy in the Treatment of Lymphoma
  39. Treatment Update on Mantle Cell Lymphoma (MCL)
  40. Progress in the Treatment of Waldenstrom’s Macroglobulinemia
  41. Worldwide Clinical Trials for Blood Cancers
  42. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
  43. Update on Cutaneous T-Cell Lymphoma
  44. Update on Marginal Zone Lymphoma
  45. Update on Diffuse Large B-Cell Lymphoma
  46. Progress in the Treatment of Follicular Lymphoma
  47. Progress in the Treatment of Hodgkin Lymphoma
  48. Treatment Update on Mantle Cell Lymphoma (MCL)
  49. Life With Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
  50. Advances in Immunotherapy in the Treatment of Lymphoma
  51. Transplantation as a Treatment Option for Blood Cancers
  52. Managing the Cost of Care When You Have Lymphoma
  53. A Guide for Coping With Childhood Lymphoma, Part II: Survivorship Care for Childhood Lymphoma Survivors
  54. A Guide for Coping With Childhood Lymphoma, Part I: Understanding Childhood Lymphoma
Back to Top
Terms of Use and Privacy Policy

By using our website, you agree to our recently updated Privacy Policy . Here you can read more about our use of cookies which help us make continuous improvements to our website. Privacy Policy.